Weight Loss · Compound File

Semaglutide for weight loss

The original GLP-1 agonist that started the revolution. FDA-approved as Ozempic (diabetes) and Wegovy (obesity). Generic research semaglutide is the most affordable GLP-1 path in the Philippines.

Avg Loss

15.0%

Trial

68wk

Frequency

Weekly

FDA

Approved

§ 01

Overview

Semaglutide is the most widely studied GLP-1 receptor agonist on the market. Phase 3 STEP trials demonstrated 14.9% average body weight reduction over 68 weeks at the 2.4mg obesity dose, and millions of patients have used it since FDA approval. In the Philippines, you have two real paths: branded Ozempic at pharmacies (intermittent stock, premium price) or research-grade generic semaglutide via verified suppliers (lower price, COA verification required).

§ 02

Brand vs research-grade

Ozempic vs generic semaglutide

Side-by-side
Property	Brand Ozempic	Generic semaglutide
Active ingredient	Semaglutide	Semaglutide
Mechanism	Identical	Identical
Form	Pre-filled injection pen	Lyophilized vial + syringe
Price (monthly)	$800–1200 USD	$50–150 USD
COA available	Pharmaceutical grade	Requires verification
Availability PH	Limited / very expensive	Available via suppliers

§ 03

Standard titration protocol

Suggested titration
Phase	Dose	Duration	Notes
Starting	0.25mg	Weeks 1–4	Tolerance building only — not therapeutic dose
Titration 1	0.5mg	Weeks 5–8	First noticeable appetite suppression
Titration 2	1mg	Weeks 9–16	Significant weight loss at this dose
Target	2.4mg	Ongoing	Maximum approved obesity dose (Wegovy)

§ 04

Who should choose semaglutide

01New to GLP-1 peptides — extensive safety data makes it the lowest-risk starting point
02Budget-conscious users — semaglutide is the most affordable GLP-1 at therapeutic doses
03Want the most studied, proven compound with decades of research
04Have type 2 diabetes — semaglutide also has strong glucose-lowering data
05Plan to step up to tirzepatide or retatrutide later — semaglutide is a good introduction to GLP-1 effects

§ 05

What to expect

Month 1

0.25mg is not a weight loss dose — it is tolerance building. Mild appetite changes. First-week nausea is common.

Month 2

At 0.5mg, clear appetite suppression. Many users report 2–4kg lost from reduced food intake alone.

Month 3–4

At 1mg, consistent weekly weight loss. Energy often improves. Body composition noticeably changing.

Month 5+

At higher doses (1.7–2.4mg), weight loss approaches the 15% clinical average. Plateau management becomes important.

↗ Related Filings